Teva Pharmaceutical Industries Ltd.

Major Shareholding Notification • Jun 17, 2024

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See

Instruction 1(b).

Check this box to indicate that a

transaction was made pursuant to a contract, instruction or written

plan for the purchase

or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

OMB APPROVAL
OMB Number:	3235-0287
Estimated average burden
hours per response	0.5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

(Print or Type Responses) 1. Name and Address of Reporting Person 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Vergis Janet S. Teva Pharmaceutical Industries Limited [ TEVA ] Director 10% Owner (Last) (First) (Middle) Officer (give title below) Other (specify below) 3. Date of Earliest Transaction (Month/Day/Year) C/O Teva Pharmaceutical Industries Ltd. 06/15/2024 124 Dvora HaNevi'a St., (Street) 6. Individual or Joint/Group Filing (Check Applicable Line) 4. If Amendment, Date Original Filed (Month/Day/Year) _ X _ Form filed by One Reporting Person
___Form filed by More than One Reporting Person Tel Aviv, L3 6944020 (City) (Zip) (State) Table I - Non-Derivative Securities Acquired Disposed of or Reneficially Owned

.
1.Title of Security	2. Transaction	2A. Deemed	3. Transaction		4. Securities Acquired			5. Amount of Securities Beneficially		7. Nature
(Instr. 3)	Date	Execution Date, if Code						(A) or Disposed of (D) Owned Following Reported	Ownership of Indirect
	i(Month/Day/Year) any		(Instr. 8)		(Instr. 3, 4 and 5)			Transaction(s)	Form:	Beneficial
		(Month/Day/Year)						(Instr. 3 and 4)		Direct (D) Ownership
									or Indirect (Instr. 4)
						(A) or			(1)
			Code		Amount	(D)	Price		(Instr. 4)
Ordinary Shares (1)	06/15/2024		M		21,108	A	(2)	64,065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

e.g. , puts, calls, warrants, options, convertible securities)
1. Title of		3. Transaction	3A. Deemed	ব		5. Number		6. Date Exercisable		7. Title and Amount			8. Price of 19. Number of	10	11. Nature
Derivative	Conversion Date							Execution Date, if Transaction of Derivative and Expiration Date		of Underlying			Derivative Derivative	Ownership of Indirect
Security		or Exercise (Month/Day/Year) any		Code		Securities		(Month/Day/Year)		Securities		Security	Securities	Form of	Beneficial
(Instr. 3)	Price of		(Month/Day/Year) (Instr. 8)			Acquired				(Instr. 3 and 4)		(Instr. 5)	Beneficially	Derivative Ownership
	Derivative					(A) or						Owned	Security:	(Instr. 4)
	Security						Disposed of						Following	Direct (D)
						(D)							Reported	or Indirect
						(Instr. 3, 4,						Transaction(s)	(I
					and 5)							(Instr. 4)	(Instr. 4)
											Amount
											Or
								Date	Expiration	Title	Number
								Exercisable Date			of
				Code		(A)	(D)				Shares
Restricted										Ordinary
Share	(2)	06/15/2024		M			21,108	(3)	(3)	Shares	21,108	\$ 0	0	D
Units										(1)

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. 1. Each restricted share unit epresents a continent, one ortinary share or , at the option of the Human Resources and Compression Committer, the cash value of one ordinary share.
3. 1. Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024.

Signatures

/s/ Dov Bergwerk as attorney-in-fact for Janet S. Vergis 06/17/2024

Date

** Signature of Reporting Person

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 18tf(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information in this form are not required to respond unless the form displays a currently valid OMB Number.